Paper: Considerations On The Use Of Adaptive Designs in Clinical Trials

Click on the link below to read this paper highlighting statistical considerations on the use of adaptive designs in clinical research written by George DeMuth Considerations On The Use Of Adaptive Designs in Clinical Trials

Recent

Stat One: Clinical Research & Product Development in 2023 January 12, 2023
CDRH Launches the Total Product Life Cycle (TPLC) Advisory Program (TAP) Pilot November 10, 2022
FDA Guidance Adjusting for Covariates in Randomized Trials October 17, 2022
FDA Guidance RWD and RWE October 5, 2022
TCT 2022 Key Takeaways September 26, 2022